Columbia University

The University of Texas MD Anderson Cancer Center and US/UK biotech Replay announced on 14 February that they are launching a new company, Syena, to advance research conducted at the cancer center o

Troubled Advaxis, Inc. may be getting a second lease on life by merging with cash-poor Ayala Pharmaceuticals, Inc. , which has a late-stage candidate for desmoid tumors, a condition with no approve

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. PhoreMost To Deploy SITESEEKER Platform

Erasca Five-Year Collaboration With MD Anderson Focused On MAPKlamp Combo Precision oncology-focused Erasca, Inc. inked a research and development collaboration on 23 August with the University of